Jilin Peng
Department Of Otolaryngology Head And Neck Surgery
Zhengzhou, China
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Construction and validation of an anoikis-related long non-coding RNA-based prognostic model for head and neck squamous cell carcinoma.
Journal: Translational cancer research
Published: December 17, 2024
Identification of an individualized immune-related miRNA pair signature for survival prediction of neoadjuvant chemoradiotherapy in esophageal squamous cell cancer.
Journal: Cancer letters
Published: December 15, 2024
Efficacy and safety of anti-PD-1 versus anti-PD-L1 in perioperative immunotherapy: A comprehensive reanalysis of randomized controlled trials.
Journal: Med (New York, N.Y.)
Published: November 29, 2024
Clinical Benefit of PD-1/PD-L1 Inhibitors as Standard First-Line Treatment in Low PD-L1-Expressing Advanced Solid Tumors: A Systematic Review and Meta-Analysis.
Journal: MedComm
Published: November 19, 2024
Expression and prognostic significance of the m6A RNA methylation regulator HNRNPC in HNSCC.
Journal: Frontiers in oncology
Published: October 25, 2024
Comparative effectiveness and safety of imported and domestic immune checkpoint inhibitors in China: A systematic review and pairwise and network meta-analyses.
Journal: Pharmacological research
Published: June 09, 2024
Contrast-Enhanced Computed Tomography-Based Machine Learning Radiomics Predicts IDH1 Expression and Clinical Prognosis in Head and Neck Squamous Cell Carcinoma.
Journal: Academic radiology
Published: May 02, 2024
Identification of an immune-related signature as a prognostic classifier for patients with early-stage head and neck squamous cell carcinoma.
Journal: Translational cancer research
Published: September 29, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026